Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
OwnerKim Zachary Travis, John Posnerinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerKim Zachary Travis, John Posnerinventors
Estimating the term…
The present invention relates to, inter alia, the use of a compound capable of inhibiting 4-hydroxyphenylpyruvate dioxygenase (HPPD) in an animal in the manufacture of a medicament for use in the treatment and/or prevention of depression. The invention also provides for the use of a compound capable of inhibiting HPPD in an animal in the manufacture of a medicament for use in the treatment of the withdrawal symptoms associated with an addictive drug which causes dopamine dependant associative learning disorders in said animal. In a particular embodiment said HPPD inhibitor is selected from the group consisting of the compound depicted as compound 1; 2; and 3.22.
The use of at least one compound capable of inhibiting 4-hydroxyphenylpyruvate dioxygenase (HPPD) in an animal in the manufacture of a medicament for use in the treatment and/or prevention of depression.
The use according to any one of the previous claims wherein said medicament comprises a selective serotonin reuptake inhibitor (SSRI) and/or a tricyclic antidepressant (tricyclic).
A kit comprising a pharmaceutically effective amount of a compound selected from the group consisting of:
A pharmaceutical composition comprising as an active ingredient a pharmaceutically effective amount of a compound selected from the group consisting of compound 1;
The use of at least one compound capable of inhibiting 4-hydroxyphenylpyruvate dioxygenase (HPPD) in an animal in the manufacture of a medicament for use in the treatment of the withdrawal symptoms associated with an addictive drug which causes dopamine dependant associative learning disorders in said animal.
A kit comprising a pharmaceutically effective amount of compound selected from the group consisting of:
A pharmaceutical composition comprising as an active ingredient a pharmaceutically effective amount of a compound selected from the group consisting of:
Dependencies are inferred from the claim text.